E-ISSN 2231-3206 | ISSN 2320-4672
 
2024, Vol: 14, Issue: 10
14 / 10Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

NJPPP Manuscript Submission Form

Case Report
Online Published: 13 Feb 2021
 


Amlodipine-induced gingival hyperplasia

Raghu N, Deepak P, Suresh R M, Manjula M J.


Cited By:2

Abstract
Drug-induced gingival hyperplasia is the increased growth of gingival epithelium and submucosa which may cause bleeding and loss of teeth. Certain anticonvulsant, immunosuppressive, and antihypertensive drugs are the underlying cause in most cases. Among them, cases due to amlodipine are very rare. Here, we discuss the topic along with a case of gingival overgrowth induced by amlodipine. A 51-year-old female presented with gingival overgrowth. She was on amlodipine because of primary hypertension. She had gingival hyperplasia increasingly growing in the last few months. Her antihypertensive regimen was changed with cessation of amlodipine. This study suggests that amlodipine may lead to gingival hyperplasia.

Key words: Gingival Hyperplasia; Calcium Channel Blockers; Amlodipine


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Raghu N
Articles by Deepak P
Articles by Suresh R M
Articles by Manjula M J
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

N R, P D, M SR, J MM. Amlodipine-induced gingival hyperplasia. Natl J Physiol Pharm Pharmacol. 2021; 11(7): 803-805. doi:10.5455/njppp.2021.11.01025202103022021

Web Style

N R, P D, M SR, J MM. Amlodipine-induced gingival hyperplasia. https://www.njppp.com/?mno=30900 [Access: November 02, 2024]. doi:10.5455/njppp.2021.11.01025202103022021

AMA (American Medical Association) Style

N R, P D, M SR, J MM. Amlodipine-induced gingival hyperplasia. Natl J Physiol Pharm Pharmacol. 2021; 11(7): 803-805. doi:10.5455/njppp.2021.11.01025202103022021


Vancouver/ICMJE Style

N R, P D, M SR, J MM. Amlodipine-induced gingival hyperplasia. Natl J Physiol Pharm Pharmacol. (2021), [cited November 02, 2024]; 11(7): 803-805. doi:10.5455/njppp.2021.11.01025202103022021


Harvard Style

N, R., P, . D., M, . S. R. & J, . M. M. (2021) Amlodipine-induced gingival hyperplasia. Natl J Physiol Pharm Pharmacol, 11 (7), 803-805. doi:10.5455/njppp.2021.11.01025202103022021


Turabian Style

N, Raghu, Deepak P, Suresh R M, and Manjula M J. 2021. Amlodipine-induced gingival hyperplasia. National Journal of Physiology, Pharmacy and Pharmacology, 11 (7), 803-805. doi:10.5455/njppp.2021.11.01025202103022021


Chicago Style

N, Raghu, Deepak P, Suresh R M, and Manjula M J. "Amlodipine-induced gingival hyperplasia." National Journal of Physiology, Pharmacy and Pharmacology 11 (2021), 803-805. doi:10.5455/njppp.2021.11.01025202103022021


MLA (The Modern Language Association) Style

N, Raghu, Deepak P, Suresh R M, and Manjula M J. "Amlodipine-induced gingival hyperplasia." National Journal of Physiology, Pharmacy and Pharmacology 11.7 (2021), 803-805. Print. doi:10.5455/njppp.2021.11.01025202103022021


APA (American Psychological Association) Style

N, R., P, . D., M, . S. R. & J, . M. M. (2021) Amlodipine-induced gingival hyperplasia. National Journal of Physiology, Pharmacy and Pharmacology, 11 (7), 803-805. doi:10.5455/njppp.2021.11.01025202103022021


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

  National Journal of Physiology, Pharmacy and Pharmacology is a monthly peer reviewed journal.  The journal is having open access polic ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information

Eldaghayes Publisher

www.eldagpublisher.com 
 
All correspondence should be addressed to:
Prof. Ibrahim Eldaghayes
Editor-in-Chief
National Journal of Physiology, Pharmacy and Pharmacology
Email: ibrahim.eldaghayes@vetmed.edu.ly